EU Business News: Ceres Acquires GlobiFer Iron Supplement, PharmaSGP Achieves Record Quarter
The latest European consumer healthcare business news: Belgium's Ceres Pharma expands its portfolio with GlobiFer; and PharmaSGP achieves its best ever quarter thanks to the recovery of the OTC market.
You may also be interested in...
Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.
The latest European business news: Galenica strengthens its porfolio in Switzerland with Spagyros; Sweden's Karo offloads OTCs to Evolan; and Ceres Pharma sold to French private-equity firm.
GSK divests non-core German OTC portfolio to local player PharmaSGP, which says it has gained "established brands" in the pain-relief and sleep-aid categories.